BTI
MDGL icon

Blue Trust Inc’s Madrigal Pharmaceuticals MDGL Stock Holding History

Blue Trust Inc’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$523 Buy
+1
New +$478 ﹤0.01% 2338
2025
Q3 		– Sell
-1
Closed -$303 – 2642
2025
Q2 		$303 Buy
+1
New +$298 ﹤0.01% 2359
2024
Q4 		– Sell
-7
Closed -$1.96K – 2758
2024
Q3 		$1.96K Buy
7
+1
+17% +$256 ﹤0.01% 2587
2024
Q2 		$1.6K Buy
+6
New +$1.43K ﹤0.01% 2475
2024
Q1 		– Sell
-19
Closed -$3K – 2509
2023
Q4 		$3K Buy
+19
New +$3.33K ﹤0.01% 2030

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Blue Trust Inc's MDGL Position: Q1 2026 in Review

Blue Trust Inc opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2026: 1 share worth $523. The stake represents ﹤0.01% of the portfolio and ranks #2338 among its holdings. This is a return to the name: Blue Trust Inc previously reported a position in MDGL as recently as Q2 2025.

Blue Trust Inc first reported a position in MDGL in Q4 2023 and has held it in 5 quarters since. The position peaked at $3K in Q4 2023. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Blue Trust Inc held 1 share of Madrigal Pharmaceuticals worth $523 as of Q1 2026.
  • Madrigal Pharmaceuticals was a new Blue Trust Inc position in Q1 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Blue Trust Inc's portfolio in Q1 2026, its #2338 holding.
  • Blue Trust Inc first reported a position in Madrigal Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • Blue Trust Inc's Madrigal Pharmaceuticals position peaked at $3K in Q4 2023.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.